Sentinel lymph node biopsy in primary breast cancer: Window to management of the axilla

World Journal of Surgery

Volumn 36, Issue 7, 2012, Pages 1453-1459

  Kumar, Ashwini ^a   Puri, Ruchir ^a   Gadgil, Pranjali V ^a   Jatoi, Ismail ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AXILLA; BREAST TUMOR; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MASTECTOMY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; REVIEW; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY, RADICAL; NEOADJUVANT THERAPY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 84864288529     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1635-8     Document Type: Conference Paper

References (41)

1. Halsted WS (1907) I. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46(1):1-19
2. Fisher B, Montague E, Redmond C et al (1977) Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer 39(6 Suppl):2827-2839
3. Devitt JE (1965) The significance of regional lymph node metastases in breast carcinoma. Can Med Assoc J 93:289-293
4. Cancer Research Campaign Working Party (1980) Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Lancet 2(8185):55-60
5. Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546-553 (Pubitemid 36951366)
6. David NK, Stewart JA, Thomas BJ et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically nodenegative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8(10):881-888
7. Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. JNCI J Natl Cancer Inst 98(9):599-609 (Pubitemid 43904843)
8. Zavagno G, De Salvo GL, Scalco G et al (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer. Ann Surg 247(2):207-213 (Pubitemid 351156760)
9. Del Bianco P, Zavagno G, Burelli P et al (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34(5):508-513 (Pubitemid 351514885)
10. Purushotham AD (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23(19):4312-4321 (Pubitemid 46209968)
11. Gill G (2008) Sentinel-lymph-node-based management or routine axillary clearance? one-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16(2):266-275
12. McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213-5219
13. Kett K, Varga G, Lukacs L (1970) Direct lymphography of the breast. Lymphology 3(1):2-12
14. Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2(6):335-339 discussion 340
15. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220(3):391-398 discussion 398-401
16. Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276(22):1818-1822 (Pubitemid 26406231)
17. Cox CE, Haddad F, Bass S et al (1998) Lymphatic mapping in the treatment of breast cancer. Oncology (Williston Park) 12(9): 1283-1292 discussion 1293-1284, 1297-1288 (Pubitemid 128617929)
18. Morrow M, Rademaker AW, Bethke KP et al (1999) Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery 126(4):714-720 discussion 720-722
19. Ashikaga T, Krag DN, Land SR et al (2010)Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102(2):111-118
20. Kell MR, Burke JP, Barry M, Morrow M (2010) Outcome of axillary staging in early breast cancer: a meta-analysis. Breast Cancer Res Treat 120(2):441-447
21. Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20(17):3628-3636 (Pubitemid 34983222)
22. Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364(5):412-421
23. Giuliano AE, Hawes D, Ballman KV et al (2011) Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 306(4):385-393
24. Duncan PG, Pope WD, Cohen MM, Greer N (1986) Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 64(6): 790-794 (Pubitemid 16118098)
25. Gentilini O, Masullo M, Rotmensz N et al (2005) Breast cancer diagnosed during pregnancy and lactation: Biological features and treatment options. Eur J Surg Oncol 31(3):232-236 (Pubitemid 40361511)
26. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN (2002) Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9(3):235-242 (Pubitemid 34298627)
27. Hidar S, Bibi M, Gharbi O et al (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Int J Surg 7(3):272-275
28. Hunt KK, Yi M, Mittendorf EA et al (2009) Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250(4):558-566
29. Mamounas EP, Brown A, Anderson S et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23(12):2694-2702 (Pubitemid 46179459)
30. Reynolds C, Mick R, Donohue JH et al (1999) Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17(6):1720-1726 (Pubitemid 29269240)
31. Krag DN (2004) NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial. Ann Surg Oncol 11(3 Suppl):208S-210S
32. Degnim AC, Griffith KA, Sabel MS et al (2003) Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 98(11):2307-2315 (Pubitemid 37466644)
33. Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10(10):1140-1151 (Pubitemid 40486808)
34. Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95(3):302-309
35. Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66
36. Mittendorf EA, Hunt KK, Boughey JC et al (2012) Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patientswith a positive sentinel lymph node. Ann Surg 255(1):109-115
37. Jeruss JS, Newman LA, Ayers GD et al (2008) Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer 112(12): 2646-2654 (Pubitemid 351969207)
38. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569-575
39. Caudle AS, Hunt KK, Kuerer HM et al (2011) Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol 18(9):2407-2412
40. Jatoi I, Chen BE, AndersonWF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25(13):1683-1690 (Pubitemid 46797948)
41. Jatoi I (2011) Axillary vs sentinel lymph node dissection for invasive breast cancer. JAMA 305(22):2288 author reply 2290-2281